Dr. Kevin Land is the Vice President of Clinical Services at Vitalant, supporting all hospital-facing services, including Reference Lab and Transfusion Services, Biotherapies (Cellular Therapy and Cord Blood Manufacturing), Therapeutic Apheresis and HPC collections, HLA, Hematology & Coagulation, and product manufacturing for research. He is also the Medical Director for the Cellular Therapy Laboratory in Tempe, Arizona and oversees the Vitalant Medical and Laboratory Directors.
Dr. Land is a Clinical Pathologist who specializes in Cellular Therapy, Transfusion Medicine, and Informatics and has focused much of his career on Improving donor and patient outcomes, multi-center standardization, and laboratory management. Dr. Land is very active at the national and international levels, most recently serving as chair of ISBTs Haemovigilance Working Groups and as board member of the International Haemovigilance Network. His current focus is on Biotherapies and is active in the Cellular Therapies Section of AABB as a member of the Cell Therapy Subgroup Steering.
Dr. Land completed his pathology residency and transfusion medicine fellowship at UT Southwestern Medical School in Dallas and Medical Informatics training at Johns Hopkins. Between 2000 and 2007 he held a joint appointment at Carter BloodCare and the Department of Pathology at UT Southwestern Medical Center in Dallas, Tx as the Medical Director of Laboratory Services, and Informatics, respectively, before joining Bonfils Blood Center as their first Chief Medical and Scientific Officer. Dr. Land joined Vitalant (then Blood Systems) in June 2011.